Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis
BackgroundThe currently available medications for treating membranous nephropathy (MN) still have unsatisfactory efficacy in inhibiting disease recurrence, slowing down its progression, and even halting the development of end-stage renal disease. There…